Proton-Based Stereotactic Ablative Radiotherapy in Early-Stage Non-Small-Cell Lung Cancer

Stereotactic ablative radiotherapy (SABR), a recent implementation in the practice of radiation oncology, has been shown to confer high rates of local control in the treatment of early stage non-small-cell lung cancer (NSCLC). This technique, which involves limited invasive procedures and reduced treatment intervals, offers definitive treatment for patients unable or unwilling to undergo an operation. The use of protons in SABR delivery confers the added physical advantage of normal tissue sparing due to the absence of collateral radiation dose delivered to regions distal to the target. This may translate into clinical benefit and a decreased risk of clinical toxicity in patients with nearby critical structures or limited pulmonary reserve. In this review, we present the rationale for proton-based SABR, principles relating to the delivery and planning of this modality, and a summary of published clinical studies.

[1]  Joe Y. Chang,et al.  Toxicity and patterns of failure of adaptive/ablative proton therapy for early-stage, medically inoperable non-small cell lung cancer. , 2011, International journal of radiation oncology, biology, physics.

[2]  Radhe Mohan,et al.  Evaluating proton stereotactic body radiotherapy to reduce chest wall dose in the treatment of lung cancer. , 2013, Medical Dosimetry.

[3]  Martin Stuschke,et al.  Potentials of robust intensity modulated scanning proton plans for locally advanced lung cancer in comparison to intensity modulated photon plans. , 2012, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[4]  T. Hashimoto,et al.  Hypofractionated high-dose proton beam therapy for stage I non-small-cell lung cancer: preliminary results of a phase I/II clinical study. , 2007, International journal of radiation oncology, biology, physics.

[5]  H. Menzel,et al.  The International Commission on Radiation Units and Measurements , 2011, Journal of the ICRU.

[6]  Joao Seco,et al.  Proton arc reduces range uncertainty effects and improves conformality compared with photon volumetric modulated arc therapy in stereotactic body radiation therapy for non-small cell lung cancer. , 2013, International journal of radiation oncology, biology, physics.

[7]  Samuel Ryu,et al.  American Society for Therapeutic Radiology and Oncology (ASTRO) and American College of Radiology (ACR) practice guideline for the performance of stereotactic body radiation therapy. , 2004, International journal of radiation oncology, biology, physics.

[8]  Zuofeng Li,et al.  Double-scattered proton-based stereotactic body radiotherapy for stage I lung cancer: a dosimetric comparison with photon-based stereotactic body radiotherapy. , 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[9]  Takuya Tomoda,et al.  Dose-volume comparison of proton radiotherapy and stereotactic body radiotherapy for non-small-cell lung cancer. , 2010, International journal of radiation oncology, biology, physics.

[10]  Hong Ye,et al.  Outcomes after stereotactic lung radiotherapy or wedge resection for stage I non-small-cell lung cancer. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  J. Slater,et al.  High-dose hypofractionated proton beam radiation therapy is safe and effective for central and peripheral early-stage non-small cell lung cancer: results of a 12-year experience at Loma Linda University Medical Center. , 2013, International journal of radiation oncology, biology, physics.

[12]  James Shackleford,et al.  Motion interplay as a function of patient parameters and spot size in spot scanning proton therapy for lung cancer. , 2013, International journal of radiation oncology, biology, physics.

[13]  J. Baulch,et al.  The Effect of Radiation Quality on Genomic DNA Methylation Profiles in Irradiated Human Cell Lines , 2011, Radiation research.

[14]  R. Pötter,et al.  Can protons improve SBRT for lung lesions? Dosimetric considerations. , 2008, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[15]  Alfons G H Kessels,et al.  Comparison of the effectiveness of radiotherapy with photons, protons and carbon-ions for non-small cell lung cancer: a meta-analysis. , 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[16]  Joe Y. Chang,et al.  Predicting radiation pneumonitis after stereotactic ablative radiation therapy in patients previously treated with conventional thoracic radiation therapy. , 2012, International journal of radiation oncology, biology, physics.

[17]  R. Ferrand,et al.  Calibration of CT Hounsfield units for proton therapy treatment planning: use of kilovoltage and megavoltage images and comparison of parameterized methods , 2013, Physics in medicine and biology.

[18]  Yuta Shibamoto,et al.  High‐dose proton therapy and carbon‐ion therapy for stage I nonsmall cell lung cancer , 2010, Cancer.

[19]  Hiroki Shirato,et al.  STEREOTACTIC RADIATION THERAPY WORKSHOP Hypofractionated Stereotactic Radiotherapy (HypoFXSRT) for Stage I Non-small Cell Lung Cancer: Updated Results of 257 Patients in a Japanese Multi-institutional Study , 2007 .

[20]  Heng Li,et al.  Clinical implementation of intensity modulated proton therapy for thoracic malignancies. , 2014, International journal of radiation oncology, biology, physics.

[21]  M. G. Sabini,et al.  Cellular and molecular effects of protons: Apoptosis induction and potential implications for cancer therapy , 2006, Apoptosis.

[22]  Joe Y. Chang,et al.  Clinical controversies: proton therapy for thoracic tumors. , 2013, Seminars in radiation oncology.

[23]  J. Fike,et al.  Efficient Production of Reactive Oxygen Species in Neural Precursor Cells after Exposure to 250 MeV Protons , 2005, Radiation research.

[24]  M. Schwarz,et al.  Proton therapy in lung cancer: clinical outcomes and technical issues. A systematic review. , 2008, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[25]  T. Delaney,et al.  Prescribing, Recording, and Reporting Proton-Beam Therapy , 2009 .

[26]  K. Nihei,et al.  High-dose proton beam therapy for Stage I non-small-cell lung cancer. , 2006, International journal of radiation oncology, biology, physics.

[27]  C. Wambi,et al.  Gamma-radiation (GR) triggers a unique gene expression profile associated with cell death compared to proton radiation (PR) in mice in vivo , 2008, Cancer biology & therapy.

[28]  T. Paz-Elizur,et al.  Evaluation of lesion clustering in irradiated plasmid DNA , 2005, International journal of radiation biology.

[29]  Radhe Mohan,et al.  Robust optimization of intensity modulated proton therapy. , 2012, Medical physics.

[30]  K. Westover,et al.  Proton SBRT for Medically Inoperable Stage I NSCLC , 2012, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[31]  T. Araki,et al.  Stereotactic hypofractionated high‐dose irradiation for stage I nonsmall cell lung carcinoma , 2004, Cancer.

[32]  T. Sakae,et al.  Induction of in situ DNA double-strand breaks and apoptosis by 200 MeV protons and 10 MV X-rays in human tumour cell lines , 2011, International journal of radiation biology.

[33]  Heng Li,et al.  On the interplay effects with proton scanning beams in stage III lung cancer. , 2014, Medical physics.

[34]  Shinji Sugahara,et al.  Proton beam therapy for patients with medically inoperable stage I non-small-cell lung cancer at the university of tsukuba. , 2010, International journal of radiation oncology, biology, physics.

[35]  Radhe Mohan,et al.  Proton stereotactic body radiation therapy for clinically challenging cases of centrally and superiorly located stage I non-small-cell lung cancer. , 2011, International journal of radiation oncology, biology, physics.

[36]  H. Sadrozinski,et al.  Development of a Head Scanner for Proton CT. , 2013, Nuclear instruments & methods in physics research. Section A, Accelerators, spectrometers, detectors and associated equipment.

[37]  Josef Korinek,et al.  Proceedings of the American Society of Clinical Oncology , 1982 .

[38]  Joao Seco,et al.  Treatment of non-small cell lung cancer patients with proton beam-based stereotactic body radiotherapy: dosimetric comparison with photon plans highlights importance of range uncertainty. , 2012, International journal of radiation oncology, biology, physics.

[39]  D. Gridley,et al.  Expression of Genes Involved in Mouse Lung Cell Differentiation/Regulation after Acute Exposure to Photons and Protons with or without Low-Dose Preirradiation , 2011, Radiation research.

[40]  H. Iwata,et al.  A retrospective comparison of proton therapy and carbon ion therapy for stage I non-small cell lung cancer. , 2013, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[41]  Lei Dong,et al.  Physics controversies in proton therapy. , 2013, Seminars in radiation oncology.

[42]  A. Lomax,et al.  Intensity modulated proton therapy and its sensitivity to treatment uncertainties 1: the potential effects of calculational uncertainties , 2008, Physics in medicine and biology.

[43]  H. O. Wyckoff,et al.  The International Commission on Radiation Units and Measurements , 2001, Journal of the ICRU.

[44]  Y. Shibamoto,et al.  Long-Term Outcome of Proton Therapy and Carbon-Ion Therapy for Large (T2a–T2bN0M0) Non–Small-Cell Lung Cancer , 2013, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[45]  P. Smith.  No-fly zone. , 2014 .

[46]  Joe Y. Chang,et al.  Therapy-Resistant Cancer Stem Cells Have Differing Sensitivity to Photon versus Proton Beam Radiation , 2013, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[47]  Joe Y. Chang,et al.  Stereotactic ablative radiation therapy for centrally located early stage or isolated parenchymal recurrences of non-small cell lung cancer: how to fly in a "no fly zone". , 2014, International journal of radiation oncology, biology, physics.